Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04049591 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Higher vs. Lower Dose Heparin for PCI

Study acronym: HD-PCI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Oct 2024 to Oct 8, 2024 Completion date: Aug 2025 to Dec 2025v8 Show 1 more changeShow less
    • Completion date: Aug 2025 to Dec 2025
  2. Re-verified, no change to tracked fieldsv7
  3. Primary completion date: Jun 2024 to Oct 2024 Completion date: Aug 2024 to Aug 2025v6 Show 1 more changeShow less
    • Completion date: Aug 2024 to Aug 2025
  4. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Jan 2023 to Jun 2024 · Start date changed from estimate of Aug 2021 to Mar 2, 2022 · Completion date: May 2023 to Aug 2024 · 1 morev5 Show 4 more changesShow less
    • Primary completion date: Jan 2023 to Jun 2024
    • Start date changed from estimate of Aug 2021 to Mar 2, 2022
    • Completion date: May 2023 to Aug 2024
    • Site details revised
  5. Start date: Aug 2020 to Aug 2021v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jan 2022 to Jan 2023 Start date: Jan 2020 to Aug 2020 · Completion date: Jan 2023 to May 2023 · Eligibility criteria shortened, about 7 wordsv3 Show 3 more changesShow less
    • Start date: Jan 2020 to Aug 2020
    • Completion date: Jan 2023 to May 2023
    • Eligibility criteria shortened, about 7 words

    See this version in full on ClinicalTrials.gov ↗

  2. Primary endpoint revised Secondary endpoints revised (2) · Study title shortened, about 4 wordsv2 Show 2 more changesShow less
    • Secondary endpoints revised (2)
    • Study title shortened, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).
Trial Details
NCT Number NCT04049591
Lead Sponsor Population Health Research Institute
Conditions Cardiovascular Diseases, Percutaneous Coronary Intervention
Enrollment 16,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov